Head-to-head · WeighScore
Auren Rx vs Science & Co
By GLP-1 ScorecardUpdated
Score comparison
The same recorded score — both grade 72.9/100 (C).
Auren Rx and Science & Co have the same recorded score after rounding the weighted total. That does not establish equivalent care or purchase terms. Compare the actual prescription, total charge, follow-up and cancellation conditions before choosing.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Auren Rx | Science & Co |
|---|---|---|
| WeighScore | 72.9/100 | 72.9/100 |
| Grade | C | C |
| Site position | #83 | #84 |
| Semaglutide | $149/mo (auto-refill; a single month with no commitment is $179) | $149/mo month-to-month ($79 only on a 12-month plan) |
| Tirzepatide | $149/mo (auto-refill; a single month with no commitment is $179) | $199/mo month-to-month ($125 only on a 12-month plan) |
| Coverage | All 50 states | Not publicly listed |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #83 · C
Strengths
- Semaglutide and tirzepatide cost the same, so the choice of molecule is clinical rather than budgetary
- A microdose lane is priced separately at $129 on auto-refill rather than folded into the standard figure
- Names its dispensing pharmacy, VialsRX, with a street address and a phone number in Houston, Texas
- Names a prescribing physician and practice, and publishes support hours of Monday to Friday, 9 AM to 6 PM Eastern
What to consider
- The $149 figure requires enrolling in auto-refill; a single month with no commitment is $179
- Two different medical groups are named for the same service — Wasef Health, PC on the contact page and FAQ, Beluga Health, P.A. in the telehealth consent
- Product pages advertise a free online visit while the Terms make the initial online visit and any laboratory testing the patient's responsibility
- The FAQ says all 50 states, the Terms say service is available only in certain states, and no list is published
- No compounding class is stated for VialsRX, so whether it operates under 503A or 503B is unknown
- NAD+ is priced at two different figures on the same site, which is not reassuring about the GLP-1 numbers
Site position #84 · C
Strengths
- States twice in its footer that "Science and Co, Inc. is not a 503A or 503B compounding facility"
- Its own FAQ names the commitment behind the headline: "Plans start at $125 a month on the 12 month plan"
- The printed saving corroborates the reference price — 125 divided by 199 is 63%, exactly the "Save 37%" shown
- "Same Price, Any Dose", with no hidden fees, no monthly membership and free shipping stated in the FAQ
- Names its operating entity and state of incorporation, and says every batch is third-party tested
What to consider
- The number it leads with is a twelve-month commitment; the per-month rates are $149 and $199
- Only two figures are published per drug, so a three- or six-month plan cannot be priced without starting an intake
- It says it is not a compounding facility but never names the pharmacy that is
- No lab or monitoring protocol is published
- Injection only on the pages read — no oral route and no brand lane
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.